Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by inforthelongoneon Jan 24, 2018 11:06pm
709 Views
Post# 27429174

RE:Aurora Cannabis and CanniMed Therapeutics

RE:Aurora Cannabis and CanniMed Therapeutics Hypothetically, today, you have 1000 ACB, you sell tomorrow at the open for say 13.75, pocketing $13,750.  You buy CMED at open at about $41.98 with your $13,750, it gives you approx. 325 shares, it’s a couple more, but call it 325. 
Now you wait for the deal to go through and you get 3.4 shares of ACB for each of your 325 of CMED, equaling 1105 ACB at implied cost of $12.65 = $13,978.25 and that is if ACB should drop to that level prior to the deal going through.  You are netting out 105 extra shares for making the switch from ACB to CMED only to end up with ACB again, am I missing something?   Does this make sense? 
Bullboard Posts